110 related articles for article (PubMed ID: 3778243)
1. Total and free serum concentrations of carbamazepine and carbamazepine-10,11-epoxide in children with epilepsy.
Agbato OA; Elyas AA; Patsalos PN; Brett EM; Lascelles PT
Arch Neurol; 1986 Nov; 43(11):1111-6. PubMed ID: 3778243
[TBL] [Abstract][Full Text] [Related]
2. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
Svinarov DA; Pippenger CE
Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662
[TBL] [Abstract][Full Text] [Related]
3. Comparison of equations for predicting bound serum concentrations of carbamazepine and carbamazepine-10, 11-epoxide after polytherapy in patients with epilepsy.
Kodama Y; Kuranari M; Kodama H; Tsutsumi K; Fujii I; Takeyama M
J Clin Pharmacol; 1995 Oct; 35(10):995-1002. PubMed ID: 8568018
[TBL] [Abstract][Full Text] [Related]
4. In vivo binding characteristics of carbamazepine and carbamazepine 10, 11-epoxide to serum proteins in monotherapy adult patients.
Kodama Y; Kuranari M; Tsutsumi K; Okamoto T; Kodama H; Yasunaga F; Fujii I; Takeyama M
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):618-21. PubMed ID: 7874378
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing simultaneous concentrations of total and free carbamazepine and carbamazepine-10, 11-epoxide in serum of children with epilepsy.
Elyas AA; Patsalos PN; Agbato OA; Brett EM; Lascelles PT
Ther Drug Monit; 1986; 8(3):288-92. PubMed ID: 3750372
[TBL] [Abstract][Full Text] [Related]
6. In vivo binding characteristics of carbamazepine and carbamazepine-10,11-epoxide to serum proteins in paediatric patients with epilepsy.
Kodama Y; Tsutsumi K; Kuranari M; Kodama H; Fujii I; Takeyama M
Eur J Clin Pharmacol; 1993; 44(3):291-3. PubMed ID: 8491247
[TBL] [Abstract][Full Text] [Related]
7. Free and total serum concentrations of carbamazepine and carbamazepine-10,11-epoxide in infancy and childhood.
Riva R; Contin M; Albani F; Perucca E; Lamontanara G; Baruzzi A
Epilepsia; 1985; 26(4):320-2. PubMed ID: 4006891
[TBL] [Abstract][Full Text] [Related]
8. Carbamazepine-10,11-epoxide in epilepsy. A pilot study.
Tomson T; Almkvist O; Nilsson BY; Svensson JO; Bertilsson L
Arch Neurol; 1990 Aug; 47(8):888-92. PubMed ID: 2375696
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
Wang RB; Liu LT; Yiu CH; Chang TY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
[TBL] [Abstract][Full Text] [Related]
10. Alpha 1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsy.
Contin M; Riva R; Albani F; Perucca E; Lamontanara G; Baruzzi A
Eur J Clin Pharmacol; 1985; 29(2):211-4. PubMed ID: 4076320
[TBL] [Abstract][Full Text] [Related]
11. The epoxide of carbamazepine.
McKauge L; Tyrer JH; Eadie MJ
Clin Exp Neurol; 1979; 16():95-104. PubMed ID: 550961
[TBL] [Abstract][Full Text] [Related]
12. Carbamazepine and carbamazepine-10,11-epoxide serum concentrations in epileptic children.
Furlanut M; Montanari G; Bonin P; Casara GL
J Pediatr; 1985 Mar; 106(3):491-5. PubMed ID: 3973787
[TBL] [Abstract][Full Text] [Related]
13. Serum carnitine levels during oxcarbazepine and carbamazepine monotherapies in children with epilepsy.
Kurul S; Dirik E; Iscan A
J Child Neurol; 2003 Aug; 18(8):552-4. PubMed ID: 13677582
[TBL] [Abstract][Full Text] [Related]
14. CSF concentrations and serum protein binding of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients.
Johannessen SI; Gerna M; Bakke J; Strandjord RE; Morselli PL
Br J Clin Pharmacol; 1976 Aug; 3(4):575-82. PubMed ID: 22216497
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy.
Eichelbaum M; Bertilsson L; Lund L; Palmér L; Sjöqvist F
Eur J Clin Pharmacol; 1976 Mar; 09(5-6):417-21. PubMed ID: 971704
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of carbamazepine and carbamazepine-10,11-epoxide in maternal and umbilical cord blood at birth: Influence of co-administration of valproic acid or enzyme-inducing antiepileptic drugs.
Kacirova I; Grundmann M; Brozmanova H
Epilepsy Res; 2016 May; 122():84-90. PubMed ID: 26991491
[TBL] [Abstract][Full Text] [Related]
17. Effect of felbamate on carbamazepine and its major metabolites.
Wagner ML; Remmel RP; Graves NM; Leppik IE
Clin Pharmacol Ther; 1993 May; 53(5):536-43. PubMed ID: 8491065
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous liquid-chromatographic determination of carbamazepine and its epoxide metabolite in plasma.
Sawchuk RJ; Cartier LL
Clin Chem; 1982 Oct; 28(10):2127-30. PubMed ID: 7127742
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update.
Bertilsson L; Tomson T
Clin Pharmacokinet; 1986; 11(3):177-98. PubMed ID: 3524954
[TBL] [Abstract][Full Text] [Related]
20. Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
Hartley R; Forsythe WI; McLain B; Ng PC; Lucock MD
Clin Pharmacokinet; 1991 Mar; 20(3):237-46. PubMed ID: 2025982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
